Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.08 CAD | -0.92% | +1.89% | +21.35% |
06/06 | Imaflex Higher as USPTO Grants Patent For ADVASEA | MT |
29/05 | Imaflex Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Valuation
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|
Capitalization 1 | 32.51 | 52.07 | 62.48 | 79.16 | 46.36 | 56.26 | - |
Enterprise Value (EV) 1 | 32.51 | 52.07 | 62.48 | 79.16 | 46.36 | 56.26 | 56.26 |
P/E ratio | - | - | - | - | - | - | - |
Yield | - | - | - | - | - | - | - |
Capitalization / Revenue | 0.4 x | 0.6 x | 0.58 x | 0.71 x | 0.5 x | 0.58 x | 0.54 x |
EV / Revenue | 0.4 x | 0.6 x | 0.58 x | 0.71 x | 0.5 x | 0.58 x | 0.54 x |
EV / EBITDA | 4.55 x | 4.08 x | 4.4 x | 5.62 x | - | 7.52 x | 6.86 x |
EV / FCF | - | - | - | - | - | - | - |
FCF Yield | - | - | - | - | - | - | - |
Price to Book | - | - | - | - | - | - | - |
Nbr of stocks (in thousands) | 50,014 | 50,064 | 51,639 | 51,739 | 52,089 | 52,089 | - |
Reference price 2 | 0.6500 | 1.040 | 1.210 | 1.530 | 0.8900 | 1.080 | 1.080 |
Announcement Date | 17/04/20 | 15/04/21 | 14/04/22 | 19/04/23 | 26/04/24 | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|
Net sales 1 | 81.07 | 86.68 | 107.5 | 111.5 | 93.59 | 97.38 | 104.4 |
EBITDA 1 | 7.144 | 12.77 | 14.19 | 14.09 | - | 7.484 | 8.205 |
EBIT | - | - | - | - | - | - | - |
Operating Margin | - | - | - | - | - | - | - |
Earnings before Tax (EBT) | - | - | - | - | - | - | - |
Net income | - | - | - | - | - | - | - |
Net margin | - | - | - | - | - | - | - |
EPS | - | - | - | - | - | - | - |
Free Cash Flow | - | - | - | - | - | - | - |
FCF margin | - | - | - | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - | - |
Announcement Date | 17/04/20 | 15/04/21 | 14/04/22 | 19/04/23 | 26/04/24 | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 |
---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | 25.71 | 31.06 | 32.12 | 26.57 | 21.78 | 23.24 | - | 22.86 | 23.01 | 27.4 |
EBITDA 1 | 3.289 | 3.828 | 4.479 | 3.454 | 2.328 | 2.257 | - | 1.126 | - | 3.114 |
EBIT | - | - | - | - | - | - | - | - | - | - |
Operating Margin | - | - | - | - | - | - | - | - | - | - |
Earnings before Tax (EBT) | - | - | - | - | - | - | - | - | - | - |
Net income | - | - | - | - | - | - | 0.438 | - | - | - |
Net margin | - | - | - | - | - | - | - | - | - | - |
EPS | - | - | - | - | - | - | 0.0100 | - | - | - |
Dividend per Share | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 14/04/22 | 25/05/22 | 23/08/22 | 24/11/22 | 19/04/23 | 24/05/23 | 29/08/23 | 29/11/23 | 26/04/24 | 29/05/24 |
Balance Sheet Analysis
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|
Net Debt | - | - | - | - | - | - | - |
Net Cash position | - | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
Free Cash Flow | - | - | - | - | - | - | - |
ROE (net income / shareholders' equity) | - | - | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - |
Assets | - | - | - | - | - | - | - |
Book Value Per Share | - | - | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - | - | - |
Capex | - | - | - | - | - | - | - |
Capex / Sales | - | - | - | - | - | - | - |
Announcement Date | 17/04/20 | 15/04/21 | 14/04/22 | 19/04/23 | 26/04/24 | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+21.35% | 41.1M | |
+1.45% | 14.13B | |
+13.91% | 9.33B | |
-12.67% | 6.73B | |
+37.20% | 1.52B | |
+13.12% | 1.42B | |
-18.82% | 1.21B | |
+13.19% | 1.11B | |
-30.44% | 921M | |
+82.46% | 878M |
- Stock Market
- Equities
- IFX Stock
- Financials Imaflex Inc.